Drug Shortage Report for HEPARIN SODIUM INJECTION, USP
Report ID | 158765 |
Drug Identification Number | 02392453 |
Brand name | HEPARIN SODIUM INJECTION, USP |
Common or Proper name | Heparin Sodium Injection, USP |
Company Name | FRESENIUS KABI CANADA LTD |
Market Status | MARKETED |
Active Ingredient(s) | HEPARIN SODIUM |
Strength(s) | 10000UNIT |
Dosage form(s) | SOLUTION |
Route of administration | SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS INTRAVENOUS |
Packaging size | 0.5mL |
ATC code | B01AB |
ATC description | ANTITHROMBOTIC AGENTS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2023-01-05 |
Estimated end date | 2023-03-01 |
Actual end date | 2023-02-11 |
Shortage status | Resolved |
Updated date | 2023-03-01 |
Company comments | Fresenius Kabi Canada regrets to advise that due to unforeseen circumstances, we have encountered a supply interruption on our Heparin Sodium Injection, USP 10 000 USP units/mL SD Vial 0.5 mL effective immediately until March 1, 2023. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v11 | 2023-03-01 | French | Compare |
v10 | 2023-03-01 | English | Compare |
v9 | 2023-01-06 | English | Compare |
v8 | 2023-01-05 | French | Compare |
v7 | 2023-01-05 | English | Compare |
v6 | 2023-01-02 | French | Compare |
v5 | 2023-01-02 | English | Compare |
v4 | 2022-11-03 | French | Compare |
v3 | 2022-11-03 | English | Compare |
v2 | 2022-04-13 | French | Compare |
v1 | 2022-04-13 | English | Compare |
Showing 1 to 11 of 11